Decoding the Epigenome and Epitranscriptome by Mass Spectrometry: From Molecular Mapping to Biomarker Discovery
Mass Spectrometry Reviews · 18.11.2026
DOI: 10.1002/mas.70054 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mass Spectrometry Reviews, online erschienen am 18.11.2026. Verfasst von Amir Saed und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, College of Science, George Mason University, Fairfax, Virginia, USA. Die Arbeit nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation.
Abstract (Originalsprache)
Epigenetic and epitranscriptomic modifications represent fundamental regulatory layers that control chromatin organization, messenger RNA (mRNA) processing, and cellular identity. Aberrant regulation of these chemical marks, including DNA and RNA methylation, hydroxymethylation, and post‐translational modifications (PTMs) of chromatin‐associated proteins, is strongly implicated in the development and progression of cancer, neurodegenerative, autoimmune, and metabolic disorders. Mass spectrometry (MS) has emerged as a powerful analytical platform for decoding these complex systems, offering high sensitivity, quantitative accuracy, and molecular specificity for characterizing epigenetic and epitranscriptomic landscapes. In this review, we provide a comprehensive overview of MS‐based strategies for qualitatively and quantitatively mapping DNA and RNA modifications at both global and site‐specific levels. Key analytical approaches, including untargeted MS workflows, isotopic labeling techniques, targeted quantification, and ion mobility spectrometry (IMS), are discussed in the context of improving detection sensitivity, accuracy, and coverage. We further highlight the integration of MS with complementary multi‐omic platforms, such as genomics, transcriptomics, and metabolomics, to enable systems‐level insights into chromatin regulation and RNA modification networks. Emerging technologies, including single‐cell and spatially resolved MS, are also discussed for their ability to resolve cellular heterogeneity and map epigenetic alterations in complex biological systems. Finally, we examine the translational potential of MS‐based epigenomic and epitranscriptomic profiling for biomarker discovery and precision medicine. Despite ongoing challenges related to sample complexity, detection of low‐abundance modifications, and data interpretation, continued advances in instrumentation, informatics, and integrative workflows are positioning MS at the forefront of molecular diagnostics, bridging the gap between mechanistic insight and clinical application.
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, College of Science, George Mason University, Fairfax, Virginia, USA.
- Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA.
- Northern Virginia Community College, Manassas, Virginia, USA.
- Center for Molecular Engineering, George Mason University, Manassas, Virginia, USA.
ORCID-Profile: Amir Saed, Fiona Devaraj, Edward Bentil, Mikell Paige, Michael Girgis
Förderung
- National Science Foundation
Zitieren
APA
Saed, A., Elemary, N., Russo, P., Paige, Z., Choi, P., Devaraj, F., Canas, H., Bertulfo, I., Saleh, A., Bentil, E., Bishop, B., Paige, M., & Girgis, M. (2026). Decoding the Epigenome and Epitranscriptome by Mass Spectrometry: From Molecular Mapping to Biomarker Discovery. Mass Spectrometry Reviews. https://doi.org/10.1002/mas.70054
Vancouver
Saed A, Elemary N, Russo P, Paige Z, Choi P, Devaraj F, et al. Decoding the Epigenome and Epitranscriptome by Mass Spectrometry: From Molecular Mapping to Biomarker Discovery. Mass Spectrometry Reviews. 2026. doi:10.1002/mas.70054
BibTeX
@article{Saed2026,
author = {Saed, Amir and Elemary, Noha and Russo, Paul and Paige, Zoe and Choi, Peter and Devaraj, Fiona and Canas, Heather and Bertulfo, Isabella and Saleh, Amany and Bentil, Edward and Bishop, Barney and Paige, Mikell and Girgis, Michael},
title = {Decoding the Epigenome and Epitranscriptome by Mass Spectrometry: From Molecular Mapping to Biomarker Discovery},
journal = {Mass Spectrometry Reviews},
year = {2026},
doi = {10.1002/mas.70054}
}
EUVIMED